• SC 79 Akt Activator: Optimizing Neuroprotection Workflows

  2026-05-14

  SC 79 stands out as a unique, cytosol-specific Akt activator, enabling precise control of cell survival pathways in both neuroprotection and metabolic disease models. This article delivers actionable protocol enhancements, troubleshooting strategies, and bridges experimental findings to practical laboratory use, with clear guidance on leveraging SC 79’s strengths for reproducible, high-impact results.

• Dissecting In Vitro Drug Response: Proliferation vs. Cell De

  2026-05-14

  Schwartz's dissertation advances in vitro cancer drug evaluation by distinguishing between proliferative arrest and cell death, using refined viability metrics. This approach clarifies drug mechanism-of-action profiling and paves the way for more accurate preclinical assessment in cancer biology.

• Th1 Lymphocytes and Microglia Drive Stress-Induced Depressio

  2026-05-13

  This study establishes a mechanistic link between chronic stress, Th1 lymphocyte–microglia interactions, and neuroinflammation in a mouse model of depression. By dissecting the contributions of the p38 MAPK pathway, the research highlights new targets for intervention and clarifies the distinct roles of immune and neuronal signaling in depression-like behaviors.

• Light-Inducible RNA-Releasing Proteins Enable Precision Gene

  2026-05-13

  This study introduces a rationally engineered light-inducible RNA-releasing protein (LIRP) that enables precise, optogenetic regulation of therapeutic gene expression at the translational level in vivo. The approach offers new control and safety for gene therapies targeting chronic and retinal diseases, with implications for tissue-specific and on-demand transgene activity.

• BKT140 (BL-8040): Applied CXCR4 Antagonism in Oncology Workf

  2026-05-12

  BKT140 (BL-8040) uniquely enables high-fidelity CXCR4-mediated chemotaxis inhibition and apoptosis induction, accelerating translational oncology and stem cell mobilization research. This guide delivers actionable workflow enhancements, troubleshooting strategies, and protocol optimization tips, leveraging insights from recent theranostic advances.

• Spermine: Endogenous Polyamine for Advanced Ion Channel Rese

  2026-05-12

  Spermine, a potent endogenous polyamine, offers unparalleled control over inward rectifier potassium channel modulation, enabling high-precision studies in cellular metabolism and protein synthesis. With robust solubility and data-backed protocol optimization, Spermine from APExBIO stands out as a critical tool for researchers driving innovation in ion channel and nuclear envelope dynamics.

• 5-Azacytidine: Optimizing DNA Demethylation in Cancer Models

  2026-05-11

  5-Azacytidine (5-AzaC) empowers researchers to reactivate silenced genes and dissect epigenetic mechanisms in cancer, with precision workflows enabling robust demethylation and apoptosis induction. This guide delivers actionable protocols, troubleshooting strategies, and advanced applications—backed by landmark studies—unveiling why APExBIO’s 5-Azacytidine is a trusted standard for multiple myeloma and leukemia research.

• YAP-TEAD Super-Enhancer Regulation in Early Surface Ectoderm

  2026-05-11

  Wang et al. (2026) dissect the central role of YAP-TEAD-driven super-enhancer networks in early surface ectoderm commitment, applying 3D genomics and CRISPR-dCas9-based perturbations to map regulatory landscapes. These findings clarify the epigenetic and transcriptional mechanisms guiding lineage specification, providing robust frameworks for regenerative and stem cell-based therapies.

• Redefining Reductive Bioconjugation: TCEP Hydrochloride in M

  2026-05-10

  Explore how Tris(2-carboxyethyl) phosphine hydrochloride (TCEP hydrochloride) is revolutionizing protein-based assay workflows and bioconjugation. Dive into advanced reduction strategies, unique capture-and-release innovations, and practical guidance for next-generation biochemical analysis.

• Neuroinflammation and Piezo2 Signaling in Trigeminal Allodyn

  2026-05-09

  Liao et al. reveal that chronic trigeminal nerve root compression induces a neuroinflammatory cascade, promoting mechanical allodynia through a Ca2+-CGRP/SP-Piezo2 axis. Their work identifies novel feedback mechanisms between neuropeptide signaling and mechanotransduction, offering new insights into trigeminal neuralgia pathogenesis.

• Primidone (Mysoline): Protocols & Precision in TRPM3/RIPK1 R

  2026-05-09

  Primidone (Mysoline) delivers selective, dual TRPM3 and RIPK1 inhibition for translational research in neurodevelopmental and neurodegenerative models. This guide distills structural insights and workflow-tested parameters to help labs harness its full potential, even in challenging disease-relevant assays.

• (-)-Norepinephrine (+)-bitartrate: Benchmarks & Research Use

  2026-05-08

  (-)-Norepinephrine (+)-bitartrate is a validated adrenergic receptor agonist with nanomolar binding affinity, used for precise cardiovascular modeling and in vitro studies. Its robust receptor selectivity and defined storage parameters make it essential for cardiomyopathy research and adrenergic signaling investigations.

• PQQ Modulates Nrf2–IGF1R Axis to Alleviate Age-Related Osteo

  2026-05-07

  This study demonstrates that pyrroloquinoline quinone (PQQ) attenuates age-associated osteoarthritis by activating Nrf2-mediated antioxidant defenses and upregulating IGF1R signaling in chondrocytes. These findings clarify a disease-modifying mechanism and point to the PQQ–Nrf2–IGF1R axis as a promising therapeutic target for osteoarthritis.

• Azithromycin in Bacterial Infection Research: Workflows & Re

  2026-05-07

  Azithromycin stands out as a macrolide antibiotic for probing bacterial protein synthesis and resistance mechanisms. This guide delivers optimized experimental workflows, troubleshooting tactics, and fresh insights from recent resistance surveillance, empowering researchers to achieve robust and reproducible results across infection and resistance models.

• Puerarin Drives Osteogenic Differentiation via Nitric Oxide

  2026-05-06

  This study demonstrates that puerarin activates the nitric oxide pathway to promote osteogenic differentiation of rat dental follicle cells. The findings advance our understanding of periodontal regeneration mechanisms and highlight the utility of NOS pathway modulation in tissue engineering research.

449 records 18/30 page Previous Next First page 上5页 1617181920 下5页 Last page